Phathom Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
Phathom Pharmaceuticals, a biopharmaceutical company focused on the
development and commercialization of novel treatments for
gastrointestinal (GI) diseases and disorders, today announced that David
Socks, Chief Executive Officer, will present at the Jefferies 2019
Healthcare Conference on Thursday, June 6, 2019 at 2:00 p.m. ET in New
York, NY.
About Phathom Pharmaceuticals
Phathom Pharmaceuticals is a biopharmaceutical company focused on the
development and commercialization of novel treatments for
gastrointestinal diseases and disorders. Phathom has licensed the
exclusive rights in the United States, Europe, and Canada to vonoprazan,
a novel potassium competitive acid blocker (P-CAB) in late stage
development for the treatment of acid-related disorders. In May 2019,
the company completed a $50 million term loan facility from Silicon
Valley Bank and a $90 million private financing from investors including
Frazier Healthcare Partners, Medicxi, RA Capital Management, Abingworth,
certain accounts managed by Janus Henderson Investors, BVF Partners LP,
Greenspring Associates, Richard King Mellon Foundation, Sahsen Ventures
and additional undisclosed institutional investors. For more information
about Phathom, visit the company's website at www.phathompharma.com.
Melanie McFaddin, representative of Wiley Bros ? Aintree Capital &Partners, LLC ("WBAC") is pleased to announce its representation of Theoris, Inc. ("Theoris" and the "Company") in its sale to CoreTech Consulting Group, LLC ("CoreTech"). Theoris'...
Banuba, a leading provider of augmented reality (AR) technology, has recently updated its Video Editor SDK ? a ready-made video content creation kit that can be integrated in an app in a few hours or even minutes.
The most impressive update is...
Just in time for its fourth anniversary, MARKT-PILOT announces the successful completion of one of Europe's largest Series A financing rounds, led by global software investor Insight Partners with participation from existing investor Capnamic. The...
Jenzabar, Inc., a leading technology innovator in higher education, today announced that company co-founder Robert A. Maginn has been reappointed as its Chief Executive Officer....
DXC Technology today announced that it will release financial results for the fourth quarter of fiscal year 2024 on Thursday, May 16, 2024, at approximately 4:15 p.m. Eastern Daylight Time (EDT).
DXC Technology senior management will host a...